Operating Highlights
- Q4 2026 Sales increased
$31 million (9 percent) to$384 million compared to$353 million in Q4 2025. All sales growth in Q4 2026 was organic, as the acquisition of ESCO Maritime Solutions (Maritime) was completed in Q3 2025. - FY 2026 Sales increased
$227 million (21 percent) to$1.3 billion compared to$1.1 billion in FY 2025. Organic sales increased$106 million (10 percent) and the Maritime acquisition added$121 million (11 percent) of inorganic revenue growth for the full year. - Q4 2026 GAAP EPS from Continuing Operations increased 14 percent to
$1.97 per share compared to$1.73 per share in Q4 2025. Q4 2026 Adjusted EPS from Continuing Operations increased 15 percent to$2.67 per share compared to$2.32 per share in Q4 2025. - FY 2026 GAAP EPS from Continuing Operations increased 25 percent to
$5.63 per share compared to$4.49 per share in FY 2025. FY 2026 Adjusted EPS from Continuing Operations increased 40 percent to$8.42 per share compared to$6.03 per share in FY 2025. - Q4 2026 Entered Orders increased
$71 million (22 percent) to$392 million (book-to-bill of 1.02x). - FY 2026 Entered Orders increased
$172 million (11 percent) to$1.7 billion (book-to-bill of 1.31x), resulting in record year-end backlog of$1.5 billion . Organic orders increased$232 million (20 percent). Net Cash provided by Operating Activities from Continuing Operations was$102 million in Q4 2026 and$296 million for FY 2026 (an increase of$95 million compared to FY 2025).
“Our employees’ hard work, expertise, and teamwork drove operational improvements and made this year’s achievements possible, building a strong foundation for continued success. Looking ahead, the addition of Megger, our record backlog, and strong positions in markets with durable long-term growth drivers reinforce our confidence in ESCO’s future.”
Segment Performance
Aerospace & Defense (A&D)
- Q4 2026 sales increased
$19.8 million (12 percent) to$190.2 million from$170.4 million in Q4 2025. Sales growth in the quarter was driven by strength inNavy and commercial aerospace. FY 2026 sales increased$174.3 million (36 percent) to$652.5 million from$478.2 million in FY 2025. Organic sales increased$53.2 million (12 percent) and Maritime added$121.1 million of inorganic revenue growth for the year. Sales growth for the year was driven by strength inNavy and commercial and military aerospace. - Q4 2026 EBIT increased
$9.5 million to$56.4 million from$46.9 million in Q4 2025. Adjusted EBIT increased$7.7 million in Q4 2026 to$56.4 million (29.7 percent margin) from$48.7 million (28.6 percent margin) in Q4 2025. FY 2026 EBIT increased$62.6 million to$187.7 million from$125.1 million in FY 2025. FY 2026 Adjusted EBIT increased$58.4 million to$188.1 million (28.8 percent margin) from$129.7 million (27.1 percent margin) in FY 2025. The increase in Adjusted EBIT was driven by leverage on higher volume and price increases, partially offset by mix and inflationary pressures for both the quarter and the year. - Q4 2026 entered orders increased
$51.7 million (36 percent) to$193.6 million (book-to-bill of 1.02). Orders strength in the quarter was driven by strongNavy and military aerospace. FY 2026 entered orders increased$59.8 million (7 percent) to$955.4 million (book-to-bill of 1.46), resulting in record year-end backlog of$1.1 billion . Organic orders increased$119.4 million (24.8 percent). Orders strength in the year was driven by strongNavy , commercial aerospace and military aerospace.
- Q4 2026 sales increased
$3.8 million (3 percent) to$114.0 million from$110.2 million in Q4 2025. Doble sales increased by$7.2 million (8 percent) and NRG sales decreased by$3.4 million (20 percent). Sales growth in the quarter was primarily driven by higher condition monitoring and services revenue at Doble, partially offset by lower renewables revenue at NRG. FY 2026 sales increased$15.0 million (4 percent) to$395.0 million from$380.0 million in FY 2025. Doble sales increased$32.7 million (10 percent) and NRG sales decreased$17.7 million (27 percent) for the year. Sales growth for the year was driven by broad strength across all product lines at Doble, partially offset by lower renewables revenue at NRG. - Q4 2026 EBIT decreased
$0.7 million to$31.2 million from$31.9 million in Q4 2025. Adjusted EBIT decreased$0.6 million in Q4 2026 to$31.4 million (27.5 percent margin) from$32.0 million (29.1 percent margin) in Q4 2025. The decrease in Adjusted EBIT in the quarter was driven by deleverage on lower volume at NRG, inflationary pressures, and mix, partially offset by price increases and leverage on higher volume at Doble. FY 2026 EBIT increased$0.5 million to$95.2 million from$94.7 million in FY 2025. FY 2026 Adjusted EBIT increased$1.1 million to$96.3 million (24.4 percent margin) from$95.2 million (25.0 percent margin) in FY 2025. The increase in Adjusted EBIT for the year was driven by leverage on higher volume at Doble and price increases, partially offset by deleverage on lower volume at NRG and inflationary pressures. - Q4 2026 entered orders increased
$11.8 million (10 percent) to$128.0 million (book-to-bill of 1.12). Doble orders increased$11.6 million (11 percent) to$112.9 million and NRG orders increased$0.2 million (1 percent) to$15.1 million compared to Q4 2025. FY 2026 entered orders increased$51.4 million (13 percent) to$454.9 million (book-to-bill of 1.15) resulting in year-end backlog of$203.4 million . Doble orders increased$64.3 million (19 percent) and NRG orders decreased$12.9 million (20 percent) for the year. For both the quarter and the year, orders were driven by broad strength across Doble’s product lines as electric utilities invested in grid maintenance and expansion, partially offset by lower renewables related to the expiration ofU.S . tax credits. - As previously disclosed, the Megger transaction closed on
October 1, 2026 . Integration planning began during the regulatory approval process, and execution of those plans and cost reduction initiatives is now under way.
RF Test & Measurement (Test)
- Q4 2026 sales increased
$7.7 million (11 percent) to$79.8 million from$72.1 million in Q4 2025. FY 2026 sales increased$37.3 million (16 percent) to$274.5 million from$237.2 million in FY 2025. Sales growth in both the quarter and the year was primarily driven by military and automotive projects, filters forU.S . government data centers and secure facilities, and industrial and medical shielding. - Q4 2026 EBIT increased
$0.6 million to$13.2 million from$12.6 million in Q4 2025. Q4 2026 Adjusted EBIT increased$1.3 million to$13.9 million (17.5 percent margin) from$12.6 million (17.5 percent margin) in Q4 2025. FY 2026 EBIT increased$6.8 million to$40.9 million from$34.1 million in FY 2025. FY 2026 Adjusted EBIT increased$9.1 million to$43.7 million (15.9 percent margin) from$34.6 million (14.6 percent margin) in FY 2025. The increase in Adjusted EBIT for both the quarter and the year was driven by leverage on higher volume and price increases, partially offset by inflationary pressures. - Q4 2026 entered orders increased
$7.9 million (13 percent) to$70.7 million . Orders strength in the quarter was driven by a large automotive order and several military projects, partially offset by lower wireless and medical shielding. FY 2026 entered orders increased$61.2 million (23 percent) to a record$326.9 million (book-to-bill of 1.19) resulting in record year-end backlog of$239.6 million . Orders strength for the year was driven by military and automotive projects, filters forU.S . government data centers and secure facilities, and industrial shielding.
Business Outlook – FY 2027
Expectations for growth in FY 2027 compared to FY 2026:
- Net sales are expected to grow 55 to 58 percent to a range of
$2.05 to$2.09 billion on a consolidated basis, with A&D growing 7 to 9 percent, USG growing 170 to 175 percent (7 to 9 percent organic growth plus Megger revenue of$640 to$660 million ), and Test growing 5 to 7 percent. - Adjusted EBIT is expected to increase approximately 51 to 55 percent with Adjusted EBIT margins of 21.2 to 21.8 percent of sales.
- Adjusted EBITDA is expected to increase approximately 53 to 57 percent with Adjusted EBITDA margins of 24.2 to 24.8 percent of sales.
- Interest is expected to be in the range of
$61 to$63 million in FY 2027. - The effective income tax rate is expected to be approximately 22.5 percent in FY 2027.
- FY 2027 Adjusted EPS is expected to increase 12 to 15 percent to a range of
$9.40 to$9.70 per share. - Q1 2027 Adjusted EPS is expected to increase 13 to 19 percent compared to Q1 2026 and be in the range of
$1.85 -$1.95 per share. - Consistent with prior years, revenues and Adjusted EPS are expected to grow sequentially throughout the year.
Dividend Payment
The next quarterly cash dividend of
2027 Annual Meeting
The 2027 Annual Meeting of the Company’s shareholders will be held on
Conference Call
The Company will host a conference call today,
VACCO Divestiture
During Q4 2025, the Company completed the sale of
Forward-Looking Statements
Statements in this press release regarding Management’s intentions, expectations and guidance for fiscal 2027, including restructuring and cost reduction actions, sales, orders, revenues, margin, earnings, Adjusted EPS, acquisition related amortization, and any other statements which are not strictly historical, are “forward-looking statements” within the meaning of the safe harbor provisions of the
Investors are cautioned that such statements are only predictions and speak only as of the date of this release, and the Company undertakes no duty to update them except as may be required by applicable laws or regulations. The Company’s actual results in the future may differ materially from those projected in the forward-looking statements due to risks and uncertainties that exist in the Company’s operations and business environment including but not limited to those described in Item 1A, “Risk Factors”, of the Company’s Annual Report on Form 10-K for the fiscal year ended
Non-GAAP Financial Measures
The financial measures EBIT, Adjusted EBIT, EBITDA, Adjusted EBITDA, and Adjusted EPS are presented in this press release. The Company defines “EBIT” as earnings before interest and taxes, “EBITDA” as earnings before interest, taxes, depreciation and amortization, “Adjusted EBIT” and “Adjusted EBITDA” as excluding the net impact of the items described in the attached Reconciliation of Non-GAAP Financial Measures, and “Adjusted EPS” as GAAP earnings per share excluding the net impact of the items described and reconciled in the attached Reconciliation of Non-GAAP Financial Measures.
EBIT, Adjusted EBIT, EBITDA, Adjusted EBITDA, and Adjusted EPS are not recognized in accordance with
About ESCO
| | ||||||||||||
| Condensed Consolidated Statements of Operations (Unaudited) | ||||||||||||
| (Dollars in thousands, except per share amounts) | ||||||||||||
| Three Months Ended 2026 | Three Months Ended 2025 | |||||||||||
| $ | 383,994 | 352,674 | ||||||||||
| Cost and Expenses: | ||||||||||||
| Cost of sales | 226,596 | 203,235 | ||||||||||
| Selling, general and administrative expenses | 64,945 | 63,333 | ||||||||||
| Amortization of intangible assets | 20,286 | 20,582 | ||||||||||
| Interest expense | 3,103 | 5,129 | ||||||||||
| Other expenses (income), net | 1,271 | 828 | ||||||||||
| Total costs and expenses | 316,201 | 293,107 | ||||||||||
| Earnings before income taxes | 67,793 | 59,567 | ||||||||||
| Income tax expense | 16,574 | 14,713 | ||||||||||
| Earnings from continuing operations | 51,219 | 44,854 | ||||||||||
| Earnings from discontinued operations, net of tax expense | ||||||||||||
| of | - | 1,156 | ||||||||||
| (Loss) gain on sale of discontinued operations, net of tax | ||||||||||||
| benefit / expense of | (129 | ) | 172,642 | |||||||||
| Net (loss) earnings from discontinued operations | (129 | ) | 173,798 | |||||||||
| Net earnings | $ | 51,090 | 218,652 | |||||||||
| Diluted - GAAP | ||||||||||||
| Continuing operations | $ | 1.97 | 1.73 | |||||||||
| Discontinued operations | (0.00 | ) | 6.70 | |||||||||
| Net earnings | $ | 1.97 | 8.43 | |||||||||
| Diluted - As Adjusted Basis | ||||||||||||
| Continuing Operations | $ | 2.67 | (1 | ) | 2.32 | (2 | ) | |||||
| Diluted average common shares | 25,985 | 25,928 | ||||||||||
| (1 | ) | Q4 2026 Adjusted EPS from continuing operations excludes | ||||||||||
| (2 | ) | Q4 2025 Adjusted EPS from continuing operations excludes | ||||||||||
| Condensed Consolidated Statements of Operations (Unaudited) | |||||||||||
| (Dollars in thousands, except per share amounts) | |||||||||||
| Year Ended 2026 | Year Ended 2025 | ||||||||||
| $ | 1,322,021 | 1,095,388 | |||||||||
| Cost and Expenses: | |||||||||||
| Cost of sales | 771,870 | 634,303 | |||||||||
| Selling, general and administrative expenses | 259,984 | 234,638 | |||||||||
| Amortization of intangible assets | 81,372 | 53,317 | |||||||||
| Interest expense | 17,095 | 17,502 | |||||||||
| Other expenses (income), net | 3,611 | 2,775 | |||||||||
| Total costs and expenses | 1,133,932 | 942,535 | |||||||||
| Earnings before income taxes | 188,089 | 152,853 | |||||||||
| Income tax expense | 41,888 | 36,554 | |||||||||
| Earnings from continuing operations | 146,201 | 116,299 | |||||||||
| Earnings from discontinued operations, net of tax expense | |||||||||||
| of | - | 10,282 | |||||||||
| Gain on sale of discontinued operations, net of tax benefit / | |||||||||||
| expense of | 1,048 | 172,642 | |||||||||
| Net earnings from discontinued operations | 1,048 | 182,924 | |||||||||
| Net earnings | $ | 147,249 | 299,223 | ||||||||
| Diluted - GAAP | |||||||||||
| Continuing operations | $ | 5.63 | 4.49 | ||||||||
| Discontinued operations | 0.04 | 7.06 | |||||||||
| Net earnings | $ | 5.67 | 11.55 | ||||||||
| Diluted - As Adjusted Basis | |||||||||||
| Continuing Operations | $ | 8.42 | (1 | ) | 6.03 | (2 | ) | ||||
| Diluted average common shares | 25,965 | 25,910 | |||||||||
| (1 | ) | FY 2026 Adjusted EPS from continuing operations excludes | |||||||||
| (2 | ) | FY 2025 Adjusted EPS from continuing operations excludes | |||||||||
| Condensed Business Segment Information (Unaudited) - Continuing Operations basis | |||||||||||||||
| (Dollars in thousands) | |||||||||||||||
| GAAP | As Adjusted | ||||||||||||||
| Q4 2026 | Q4 2025 | Q4 2026 | Q4 2025 | ||||||||||||
| Aerospace & Defense | $ | 190,168 | 170,373 | 190,168 | 170,373 | ||||||||||
| USG | 114,019 | 110,211 | 114,019 | 110,211 | |||||||||||
| Test | 79,807 | 72,090 | 79,807 | 72,090 | |||||||||||
| Totals | $ | 383,994 | 352,674 | 383,994 | 352,674 | ||||||||||
| EBIT | |||||||||||||||
| Aerospace & Defense | $ | 56,364 | 46,893 | 56,405 | 48,660 | ||||||||||
| USG | 31,245 | 31,933 | 31,410 | 32,019 | |||||||||||
| Test | 13,176 | 12,588 | 13,927 | 12,588 | |||||||||||
| Corporate | (29,889 | ) | (26,718 | ) | (9,319 | ) | (8,852 | ) | |||||||
| Consolidated EBIT | 70,896 | 64,696 | 92,423 | 84,415 | |||||||||||
| Less: Interest expense | (3,103 | ) | (5,129 | ) | (1,095 | ) | (5,129 | ) | |||||||
| Less: Income tax expense | (16,574 | ) | (14,713 | ) | (21,987 | ) | (19,248 | ) | |||||||
| Net earnings | $ | 51,219 | 44,854 | 69,341 | 60,038 | ||||||||||
| Note 1: Adjusted net earnings of | |||||||||||||||
| Note 2: Adjusted net earnings of | |||||||||||||||
| EBITDA Reconciliation to Net earnings: | Q4 2026 - | Q4 2025 - | |||||||||||||
| Q4 2026 | Q4 2025 | As Adj | As Adj | ||||||||||||
| Consolidated EBITDA | $ | 97,467 | 91,316 | 101,368 | 93,328 | ||||||||||
| Less: Depr & Amort | (26,571 | ) | (26,620 | ) | (8,945 | ) | (8,913 | ) | |||||||
| Consolidated EBIT | 70,896 | 64,696 | 92,423 | 84,415 | |||||||||||
| Less: Interest expense | (3,103 | ) | (5,129 | ) | (1,095 | ) | (5,129 | ) | |||||||
| Less: Income tax expense | (16,574 | ) | (14,713 | ) | (21,987 | ) | (19,248 | ) | |||||||
| Net earnings | $ | 51,219 | 44,854 | 69,341 | 60,038 | ||||||||||
| Condensed Business Segment Information (Unaudited) - Continuing Operations basis | |||||||||||||||
| (Dollars in thousands) | |||||||||||||||
| GAAP | As Adjusted | ||||||||||||||
| FY 26 | FY 25 | FY 26 | FY 25 | ||||||||||||
| Aerospace & Defense | $ | 652,509 | 478,192 | 652,509 | 478,192 | ||||||||||
| USG | 394,995 | 379,995 | 394,995 | 379,995 | |||||||||||
| Test | 274,517 | 237,201 | 274,517 | 237,201 | |||||||||||
| Totals | $ | 1,322,021 | 1,095,388 | 1,322,021 | 1,095,388 | ||||||||||
| EBIT | |||||||||||||||
| Aerospace & Defense | $ | 187,736 | 125,139 | 188,055 | 129,676 | ||||||||||
| USG | 95,243 | 94,741 | 96,339 | 95,159 | |||||||||||
| Test | 40,873 | 34,111 | 43,681 | 34,576 | |||||||||||
| Corporate | (118,668 | ) | (83,636 | ) | (37,641 | ) | (36,994 | ) | |||||||
| Consolidated EBIT | 205,184 | 170,355 | 290,434 | 222,417 | |||||||||||
| Less: Interest expense | (17,095 | ) | (17,502 | ) | (8,224 | ) | (17,502 | ) | |||||||
| Less: Income tax | (41,888 | ) | (36,554 | ) | (63,534 | ) | (48,527 | ) | |||||||
| Net earnings | $ | 146,201 | 116,299 | 218,676 | 156,388 | ||||||||||
| Note 1: Adjusted net earnings of | |||||||||||||||
| Note 2: Adjusted net earnings of | |||||||||||||||
| EBITDA Reconciliation to Net earnings: | FY 26 - | FY 25 - | |||||||||||||
| FY 26 | FY 25 | As Adj | As Adj | ||||||||||||
| Consolidated EBITDA | $ | 311,828 | 245,376 | 326,550 | 256,303 | ||||||||||
| Less: Depr & Amort | (106,644 | ) | (75,021 | ) | (36,116 | ) | (33,886 | ) | |||||||
| Consolidated EBIT | 205,184 | 170,355 | 290,434 | 222,417 | |||||||||||
| Less: Interest expense | (17,095 | ) | (17,502 | ) | (8,224 | ) | (17,502 | ) | |||||||
| Less: Income tax expense | (41,888 | ) | (36,554 | ) | (63,534 | ) | (48,527 | ) | |||||||
| Net earnings | $ | 146,201 | 116,299 | 218,676 | 156,388 | ||||||||||
| Condensed Consolidated Balance Sheets (Unaudited) | ||||||
| (Dollars in thousands) | ||||||
2026 | 2025 | |||||
| Assets | ||||||
| Cash and cash equivalents | $ | 93,294 | 101,350 | |||
| Accounts receivable, net | 262,032 | 253,554 | ||||
| Contract assets | 143,788 | 90,730 | ||||
| Inventories | 228,564 | 217,807 | ||||
| Other current assets | 36,554 | 25,065 | ||||
| Total current assets | 764,232 | 688,506 | ||||
| Property, plant and equipment, net | 178,204 | 172,493 | ||||
| Intangible assets, net | 649,701 | 723,973 | ||||
| 762,403 | 761,931 | |||||
| Operating lease assets | 45,416 | 47,707 | ||||
| Other assets | 20,592 | 15,778 | ||||
| $ | 2,420,548 | 2,410,388 | ||||
| Liabilities and Shareholders' Equity | ||||||
| Current maturities of long-term debt | $ | 0 | 20,000 | |||
| Accounts payable | 120,118 | 96,534 | ||||
| Contract liabilities | 295,789 | 216,590 | ||||
| Current income tax payable | 6,511 | 62,007 | ||||
| Other current liabilities | 127,231 | 113,017 | ||||
| Total current liabilities | 549,649 | 508,148 | ||||
| Deferred tax liabilities | 105,860 | 112,390 | ||||
| Non-current operating lease liabilities | 42,392 | 44,403 | ||||
| Other liabilities | 31,611 | 38,576 | ||||
| Long-term debt | 14,000 | 166,000 | ||||
| Shareholders' equity | 1,677,036 | 1,540,871 | ||||
| $ | 2,420,548 | 2,410,388 | ||||
| Consolidated Statements of Cash Flows (Unaudited) | ||||||
| (Dollars in thousands) | ||||||
| Year Ended | Year Ended | |||||
| Cash flows from operating activities: | ||||||
| Net earnings | $ | 147,249 | 299,223 | |||
| (Earnings) loss from discontinued operations | (1,048 | ) | (182,924 | ) | ||
| Adjustments to reconcile net earnings to net cash | ||||||
| provided by operating activities: | ||||||
| Depreciation and amortization | 106,644 | 75,021 | ||||
| Stock compensation expense | 14,333 | 10,671 | ||||
| Changes in assets and liabilities | 35,391 | 9,381 | ||||
| Effect of deferred taxes | (6,149 | ) | (10,976 | ) | ||
| Other | (825 | ) | - | |||
| Net cash provided by operating activities - continuing operations | 295,595 | 200,396 | ||||
| Net cash (used) provided by operating activities - discontinued operations | (58,918 | ) | 41,543 | |||
| Net cash provided by operating activities | 236,677 | 241,939 | ||||
| Cash flows from investing activities: | ||||||
| Acquisition of business, net of cash acquired | (10,232 | ) | (472,006 | ) | ||
| Capital expenditures | (34,096 | ) | (36,322 | ) | ||
| Additions to capitalized software and other | (11,055 | ) | (15,844 | ) | ||
| Other | 3,248 | - | ||||
| Net cash used by investing activities - continuing operations | (52,135 | ) | (524,172 | ) | ||
| Net cash provided by investing activities - discontinued operations | 1,540 | 268,383 | ||||
| Net cash used by investing activities | (50,595 | ) | (255,789 | ) | ||
| Cash flows from financing activities: | ||||||
| Proceeds from long-term debt | 149,000 | 661,000 | ||||
| Principal payments on long-term debt and short-term borrowings | (321,000 | ) | (597,000 | ) | ||
| Dividends paid | (8,290 | ) | (8,262 | ) | ||
| Debt issuance costs | (1,456 | ) | - | |||
| Other | (10,725 | ) | (6,197 | ) | ||
| Net cash (used) provided by financing activities - continuing operations | (192,471 | ) | 49,541 | |||
| Net cash used by financing activities - discontinued operations | - | - | ||||
| Net cash (used) provided by financing activities | (192,471 | ) | 49,541 | |||
| Effect of exchange rate changes on cash and cash equivalents | (1,667 | ) | (304 | ) | ||
| Net (decrease) increase in cash and cash equivalents | (8,056 | ) | 35,387 | |||
| Cash and cash equivalents, beginning of period | 101,350 | 65,963 | ||||
| Cash and cash equivalents, end of period | $ | 93,294 | 101,350 | |||
| Other Selected Financial Data (Unaudited) | ||||||||||||||
| (Dollars in thousands) | ||||||||||||||
| Backlog And Entered Orders - Q4 2026 | A&D | USG | Test | Total | ||||||||||
| Beginning Backlog - | $ | 1,102,446 | 189,426 | 248,643 | 1,540,515 | |||||||||
| Entered Orders | 193,605 | 127,970 | 70,720 | 392,295 | ||||||||||
| Sales | (190,168 | ) | (114,019 | ) | (79,807 | ) | (383,994 | ) | ||||||
| Ending Backlog - | $ | 1,105,883 | 203,377 | 239,556 | 1,548,816 | |||||||||
| Backlog And Entered Orders - FY 2026 | A&D | USG | Test | Total | ||||||||||
| Beginning Backlog - | $ | 803,002 | 143,460 | 187,175 | 1,133,637 | |||||||||
| Entered Orders | 955,390 | 454,912 | 326,898 | 1,737,200 | ||||||||||
| Sales | (652,509 | ) | (394,995 | ) | (274,517 | ) | (1,322,021 | ) | ||||||
| Ending Backlog - | $ | 1,105,883 | 203,377 | 239,556 | 1,548,816 | |||||||||
| Reconciliation of Non-GAAP Financial Measures (Unaudited) | |||
| EPS – Adjusted Basis Reconciliation – Q4 2026 | |||
| EPS Continuing Operations– GAAP Basis – Q4 2026 | $ | 1.97 | |
| Adjustments (defined below) | 0.70 | ||
| EPS Continuing Operations– As Adjusted Basis – Q4 2026 | $ | 2.67 | |
| Adjustments of | |||
| and acquisition costs at Corporate related to the Megger acquisition | |||
| and | |||
| EPS – Adjusted Basis Reconciliation – Q4 2025 | |||
| EPS Continuing Operations– GAAP Basis – Q4 2025 | $ | 1.73 | |
| Adjustments (defined below) | 0.59 | ||
| EPS Continuing Operations– As Adjusted Basis – Q4 2025 | $ | 2.32 | |
| Adjustments of | |||
| step-up charges, | |||
| EPS – Adjusted Basis Reconciliation – FY 2026 | |||
| EPS Continuing Operations– GAAP Basis – FY 2026 | $ | 5.63 | |
| Adjustments (defined below) | 2.79 | ||
| EPS Continuing Operations – As Adjusted Basis – FY 2026 | $ | 8.42 | |
| Adjustments of | |||
| charges within Test, USG and A&D segments, | |||
| acquisition costs related to the Megger acquisition, and | |||
| related amortization. | |||
| EPS – Adjusted Basis Reconciliation – FY 2025 | |||
| EPS Continuing Operations– GAAP Basis – FY 2025 | $ | 4.49 | |
| Adjustments (defined below) | 1.54 | ||
| EPS Continuing Operations – As Adjusted Basis – FY 2025 | $ | 6.03 | |
| Adjustments of | |||
| acquisition costs, | |||
| acquisition related amortization. | |||
SOURCE
Source: